These data indicate that co-expression of CAV1 and TGFB1 frequently occurs in HCC, as was previously suggested in other kind of tumours, such as prostate cancer.33 This would have marked consequences on the HCC cell response to TGF-β. The gene discussed is TGFB1; the disease is neoplasm.